Pages

Thursday, June 15, 2017

Pharma Reviews: Why is Indian pharma so blasé about tackling disease within?

Pharmaceutical companies could have been better off, if they had paid closer attention to regulatory compliance for the US generic market. While this ...
Read more: Why is Indian pharma so blasé about tackling disease within?